Skip to main content
. 2021 Nov 15;13(11):1933. doi: 10.3390/pharmaceutics13111933

Figure 1.

Figure 1

Schematic illustration of photosensitizers-loaded nanocarriers in PDT for the treatment of cancer: (a) polymeric nanoparticles—reprinted with permission from reference [84], Copyright 2020, American Chemical Society; (b) dendrimers—reprinted with permission from reference [85], Copyright 2015, Elsevier; (c) liposomes—reprinted with permission from reference [86], Copyright 2019, Elsevier; (d) carbon-based nanoparticles—reprinted with permission from reference [87], Copyright 2008, American Chemical Society; (e) gold nanoparticles—reprinted with permission from reference [70], Copyright 2013, American Chemical Society; (f) silver nanoparticles–reprinted with permission from reference [88], Copyright 2016, American Chemical Society; (g) magnetic nanoparticles—reprinted with permission from reference [89], Copyright 2013, American Chemical Society; and (h) mesoporous silica nanoparticles—reprinted with permission from reference [90], Copyright 2015, American Chemical Society.